In a considerable win for patients who need compounded medications, the International Academy of Compounding Pharmacists (IACP), working with the DQSA Coalition, is very pleased to announce that the President has signed the Congressional Omnibus bill into law, H.R. 244, which provides funding through September 30, 2017, and includes language that addresses the Memorandum of Understanding, office-use, and pharmacy inspections.
Your genetic makeup helps determine how much you get out of dieting and exercising. Researchers now aim to identify the genes that determine the effect that diabetes patients get from diet and exercise. If the researchers succeed in identifying the gene variants they are looking for, the project could pave the way for improved personalized prevention and treatment of type 2 diabetic patients.
Coming up with new drug delivery techniques that can precisely target cancer cells, while leaving healthy tissue unharmed, has been a major goal for cancer researchers in recent years. Scientists at the University of Manchester have been testing a new approach that relies on liposomes. The new studies demonstrate for the first time how they can be built to include a temperature control, which could be an effective way of targeting treatment towards cancer cells while leaving healthy cells unharmed.
The world is facing the threat of ‘superbugs’ as these bacteria dubbed as methicillin-resistant Staphylococcus aureus (MRSA) have evolved into one of the most difficult-to-treat pathogens. MRSA is a bacteria that is resistant to many antibiotics. In the external community, most MRSA infections are skin infections. In medical facilities, MRSA causes life-threatening bloodstream infections, pneumonia and surgical site infections. A new study suggests that treatment with the wrong antibiotic could make MRSA-induced infections worse.
The virtual doctor visit has arrived. The consulting firm Deloitte has predicted that out of an average 600 million general practitioner appointments in the U.S. and Canada this year, up to 75 million could be e-visits. Even if only 30% to 40% of office visits are replaced by e-visits, that could make up a $50 to $60 billion market. Insurers, hospitals, and even drugstore giant Walgreens are embracing the technology as a way to control costs and deliver more care in the face of a growing doctor shortage.